Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).

@article{Cust2007MetabolicSP,
  title={Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).},
  author={Anne E Cust and Rudolf Kaaks and Christine M Friedenreich and F. Bonnet and Martine Laville and Anne Tj\onneland and Anja Olsen and Kim Overvad and Marianne Uhre Jakobsen and V{\'e}ronique Chaj{\`e}s and Francoise Clavel-Chapelon and Marie-Christine Boutron-Ruault and Jakob P Linseisen and Annekatrin Lukanova and H. B{\"o}ing and Tobias Pischon and Antonia Trichopoulou and Bamia Christina and Dimitirios Trichopoulos and Domenico Palli and Franco Berrino and Salvatore Panico and Rosario Tumino and Carlotta Sacerdote and Inger Torhild Gram and Eiliv Lund and Jos{\'e} Ram{\'o}n Quir{\'o}s and Noemie Travier and Carmen Mart{\'i}nez-Garc{\'i}a and N Guerrini de Larra{\~n}aga and M D Chirlaque and Eva Ardanaz and G{\"o}ran GB Berglund and Eva A Lundin and Hendrik Bas Bueno-de-Mesquita and Fr{\"a}nzel J. B. van Duijnhoven and P. H. Peeters and Sheila Anne Bingham and Kay-Tee Khaw and Naomi E. Allen and Timothy J Key and Pietro Ferrari and Sabina Rinaldi and Nadia Slimani and Elio Riboli},
  journal={Endocrine-related cancer},
  year={2007},
  volume={14 3},
  pages={755-67}
}
To clarify the role of metabolic factors in endometrial carcinogenesis, we conducted a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC), and examined the relation between prediagnostic plasma lipids, lipoproteins, and glucose, the metabolic syndrome (MetS; a cluster of metabolic factors) and endometrial cancer risk. Among pre- and postmenopausal women, 284 women developed endometrial cancer during follow-up. Using risk set sampling, 546… CONTINUE READING